Better Therapeutics, Inc. (NASDAQ: BTTX) reported Q2 EPS of ($0.42), $0.03 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Better Therapeutics, Inc. (BTTX) click here.